DCGI sees Merck drug less effective against moderate Covid: Report

Aurobindo Pharma Ltd wants to discontinue a late-stage trial of Merck drug in moderate Covid-19 patients, DCGI's expert committee said on Friday

from mint - Science https://ift.tt/3uRv7Sz